Fulltext
This part is available in the PDF file.
Nephro-Urology Monthly
Outlines
Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity
Author(s):
1Department of Urology, Rigshospitalet, State University hospital, Copenhagen, Denmark
Published online:Mar 01, 2012
Article type:Review Article
Received:May 18, 2019
Accepted:Aug 29, 2011
How to Cite:Rohrsted M, Nordsten C, Bagi P. Onabotulinum Toxin A (Botox®) in the Treatment of Neurogenic Bladder Overactivity. Nephro-Urol Mon. 2012;4(2):e93974. doi:
Abstract
References
- 1.The references are available in the PDF file.
Copyright
© 2012, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Similar Articles
30
Apr
2011
Botulinum toxin-A injections in children with neurogenic bladder
Pawel Kroll,
Jolanta Soltysiak,
Marek Murias,
Magdalena Skrzypczak,
Jacek Zachwieja,
Jacek Zachwieja
Kroll P, Soltysiak J, Murias M, Skrzypczak M, Zachwieja J, et al. Botulinum toxin-A injections in children with neurogenic bladder. Nephro-Urol Mon. 2011;3(2):. doi:
17
Aug
2021
The Effect of OnabotulinumtoxinA on the Symptoms and Quality of Life in Women with Urge Urinary Incontinence
Firoozeh Veisi,
Hossein Abdi,
Masoumeh Bayati
Veisi F, Abdi H, Bayati M. The Effect of OnabotulinumtoxinA on the Symptoms and Quality of Life in Women with Urge Urinary Incontinence. J Clin Res Paramed Sci. 2021;10(2):e111274. doi: https://doi.org/10.5812/jcrps.111274
26
Apr
2017
Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?
Tom Marcelissen,
Mohammad Sajjad Rahnama’i,
Beverley Brierley,
Brigitte Schurch,
Peter De Vries
Marcelissen T, Rahnama’i MS, Brierley B, Schurch B, Vries PD. Treatment Failure of Botulinum Toxin A in Patients with Idiopathic Overactive Bladder: Why Do Patients Discontinue Treatment?. Nephro-Urol Mon. 2017;9(3):e46569. doi: https://doi.org/10.5812/numonthly.46569
13
Mar
2021
Relationship between Obsessive-compulsive Disorder and Overactive Bladder Syndrome
Farzad Allameh,
Mahtab Motamed,
Mohammad Poury,
Ali Tayyebiazar,
Saleh Ghiasy,
Morteza Fallah-Karkan
,et al.Allameh F, Motamed M, Poury M, Tayyebiazar A, Ghiasy S, et al. Relationship between Obsessive-compulsive Disorder and Overactive Bladder Syndrome. Iran J Psychiatry Behav Sci. 2021;15(1):e101858. doi: https://doi.org/10.5812/ijpbs.101858
12
Jan
2025
Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis
Seyede Zahra Emami Razavi,
Mohaddeseh Azadvari,
Omid Mirmosayyeb,
Saeed Vaheb,
Mahsa Ghajarzadeh,
Alireza Teymouri
,et al.Emami Razavi SZ, Azadvari M, Mirmosayyeb O, Vaheb S, Ghajarzadeh M, et al. Botulinum Toxin Injection for Treating Spasticity in Multiple Sclerosis Patients: A Systematic Review and Meta-Analysis. Middle East J Rehabil Health Stud. 2025;12(2):e156825. doi: https://doi.org/10.5812/mejrh-156825
Comments
Number of Comments:0Cited by
- Scopus by DOI: 0
Last Update: 2 days ago
- Scopus by Title: 9
Last Update: 2 days ago
- Scopus by Title (Ref): 10
Last Update: 2 days ago
- CrossRef: 0
Last Update: 2 days ago
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Search Relations
Author(s):
Related Articles